Related Experiment Video
Updated: Jul 25, 2026
15:09
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
Microbiome, Parkinson's Disease and Molecular Mimicry
Fabiana Miraglia1,2, Emanuela Colla3
1Department of Pharmacy, University of Pisa, via Bonanno 6, 56126 Pisa, Italy. miragliafabiana@gmail.com.
Cells
|March 15, 2019
Summary
The gut microbiota may influence Parkinson's Disease (PD) development. Bacterial products can promote alpha-synuclein aggregation and inflammation, potentially contributing to PD pathology.
Area of Science:
- Neuroscience
- Microbiology
- Gastroenterology
Background:
- Parkinson's Disease (PD) is a neurodegenerative disorder primarily affecting motor function.
- Lewy bodies, a hallmark of PD, are found outside the central nervous system (CNS), including the olfactory bulbs and enteric nervous system.
- Alpha-synuclein (αS) aggregation and prion-like propagation are key pathological features.
Purpose of the Study:
- To review the role of the microbiota in Parkinson's Disease (PD) pathology.
- To investigate mechanisms of microbiota-host interactions implicated in PD onset.
- To explore how microbial factors influence alpha-synuclein (αS) aggregation and pro-inflammatory responses.
Main Methods:
- Literature review of current research on microbiota and PD.
- Analysis of mechanisms involving bacterial amyloid proteins and metabolites.
- Examination of gut-brain axis interactions in PD pathogenesis.
Main Results:
- The microbiota is increasingly recognized for its potential role in PD.
- Bacterial amyloid proteins and metabolites may influence αS aggregation.
- A pro-inflammatory gut environment, potentially driven by microbiota, may contribute to PD.
Conclusions:
- While no single microbial species is definitively linked to PD, microbiota-host interactions are crucial.
- Further research is needed to elucidate the specific harmful interactions between the microbiota and the host in PD pathogenesis.
- Understanding these interactions is vital for exploring the relevance of the microbiota in PD development.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:22Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...